|
Cancer
is the #2 cause of death in the United States costing the American
economy a whopping $107 billion each year. Cancer drugs alone
cost around $20 billion a year but that number will grow substantially
to $30 billion by 2003 and even higher in the future. There are
currently 175 new cancer products being developed by numerous
companies. Technology Investor Magazine research indicates that
the following six companies have the best shot of finding new
blockbuster cancer drugs: Genentech (DNA), Human Genome Sciences
(HGSI), IDEC Pharmaceuticals (IDPH), Medarex (MEDX), Millennium
Pharmaceuticals (MLNM) and Protein Design Labs (PDLI). April 7, 2001: Four companies that have cancer vaccines in Phase III trials ? they are AVI BioPharma (AVII), Biomira (BIOM), Dendreon (DNDN) and Progenics (PGNX). The Cancer
Drug List also includes other companies that may cash in on the
tremendous amount of money that is spent on this terrible disease
if they develop their own blockbuster drugs. You might be interested
in our broader Drug
Stock List, Biotech
List or Pharmaceutical
Stock List.
|
AEZS AGEN AMGN ARIA AVXT AZN BIIB BIOM BMY CELG CTIC EXEL GERN HRBR IMGN JNJ LGND ONCY OXGN PDLI PGNX PPHM QLT.TO SGEN SRPT QLTI VICL
Let me see a chart at Big
Charts
Let me search
for more news
SEARCH
YAHOO NEWS
No warranty or guarantee
is given as to the completeness or thoroughness of these lists.
Please do your own due diligence.
( Disclaimer ) ( Contact us ) ( About us ) ( Advertise with us ) ( Search Site )